Central Nervous System Diseases

Bypassing the blood-brain barrier remains an obstacle for novel therapeutics. Healio spoke to Thomas Chen, MD, PhD, founder and CEO of NeOnc, to find out how a novel nasal spray formulation to treat brain cancer overcomes these challenges.

Within 3 months after acute ischemic stroke, current smokers are at greater risk for unfavorable functional outcomes than patients who quit smoking or never started, according to research published in Stroke.